Clinical Trial Update: Zephyr Valve Japan Post-Marketing Surveillance

View source ↗

Summary

Post-marketing surveillance trial in Japan evaluating the Zephyr Valve for emphysema and COPD; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• Zephyr Valve

Snippet

Sponsor: Pulmonx Corporation | Conditions: Emphysema, COPD | Status: RECRUITING